Contents
On this page
- Declaration of the review type and adherence to its reporting guideline
- Reproducible reporting of the search strategy
- Reporting of screening procedures and resolution of disagreement
- Reconciliation of study counts before submission
- Critical appraisal of included studies in an emerging field
- Synthesis in place of sequential narration
- Use of a verifiable academic register
- Statement of known limitations
- Key points
- Application to your study
- Frequently asked questions
Academy · Research Writing · literature review do’s and don’ts
Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis
The usability of a health care literature review depends chiefly on procedure rather than style. Authors should declare the review type and report it according to the relevant guideline, record the search so that an independent reader could repeat it, state who screened the records, ensure that the numbers reconcile, and appraise the included studies rather than merely describing them. The remaining elements concern the quality of the writing.
The principal question for a reader of a literature review is whether its account of the literature is reliable. The information needed to answer this question lies in the methodological reporting: the declared review type, the search, the screening, the consistency of the counts, and whether the studies were appraised or merely reported. The recommendations below follow that order, and each is paired with the practice it replaces. The worked examples are drawn from reviews of blockchain for health data sharing, a rapidly growing literature in which the common methodological failures are all evident.
Learning objectives
- The reporting guideline applicable to each review type and the requirements of each
- The preparation of a search section that an independent reader could repeat
- The reconciliation of record counts in the abstract, flow diagram and main text
- The objective appraisal of an emerging literature, without either dismissing or overstating it
- The distinction between sequential narration and synthesis at the level of individual sentences
- The limitations that should be stated explicitly rather than left for a reviewer to identify
Common misconceptions
- “A thorough review is a comprehensive one, so the search should be described as comprehensive.” The term “comprehensive” is unverifiable and conveys no information to the reader. A search is made credible by its specification: the sources and their interfaces, coverage dates, the executed strategy and the supplementary methods. PRISMA-S was developed for this purpose and comprises sixteen items covering the databases, dates, full strategies and supplementary methods used.
- “A scoping review is an abbreviated systematic review.” A scoping review addresses a different question, mapping the extent and nature of a literature rather than estimating an effect, and it has its own reporting standard. PRISMA-ScR comprises 20 essential items plus 2 optional ones, developed by a 24-member expert panel working with 2 research leads. Reporting a scoping review against the main PRISMA checklist omits the items its readers require.
- “Minor discrepancies in the number of included studies are unimportant.” Such discrepancies are among the first features a methodological reviewer checks, and they are sufficiently common to justify a deliberate reconciliation step. The systematic review by Sabiri, Sousa and Rocha of privacy-preserving blockchain applications in healthcare, in Multimedia Tools and Applications, reports 58 included studies in its abstract and 52 in its body, a published, peer-reviewed example of the type of inconsistency that undermines a reader’s confidence in the reported figures.
- “A technology with a large literature must be close to clinical use.” Volume and maturity are independent. A systematic review of blockchain for health data sharing analysed 334 studies, excluding one retracted paper, and found that most proposals were at technology readiness level 3, that is, experimental proof of concept. A review that counts papers without assessing the maturity of the work they describe conveys an impression contrary to that supported by the evidence.
- “Critical appraisal is required only for a systematic review.” Appraisal is required for any review that makes a claim about what the literature shows, because without it the most prominent study and the most rigorous study carry equal weight. What varies by review type is whether appraisal is formal, instrument-based and reported for each study, not whether study quality is considered at all.
Declaration of the review type and adherence to its reporting guideline
Do name the review type being produced, define it in the methods, and report against the guideline that corresponds to it. Don’t use “literature review” as though it denoted a method; it denotes a family of methods. Grant and Booth’s typology in the Health Information and Libraries Journal characterised 14 review types, each by its search, appraisal, synthesis and analysis requirements; selecting the type therefore determines the method before any writing begins 39.
The consequence for reporting is concrete. A systematic review is reported against PRISMA 2020, with PRISMA-S for the search 31,32. A scoping review is reported against PRISMA-ScR, published by Tricco and colleagues in the Annals of Internal Medicine — 20 essential items plus 2 optional items, developed by a 24-member expert panel working with 2 research leads 37. These additional and differing items are not bureaucratic: they provide the information that a reader of a mapping review requires and that a reader of an effect review does not 37.
Don’t allow the title to promise more than the method delivers. “A systematic review of” in the title of a chapter with one database, no appraisal step and screening by a single reviewer is a claim that readers will test against the methods section and find unsupported. Describing the same work as a narrative or scoping review, defining it, and drawing conclusions appropriate to it carries no cost and secures the reader’s trust. The page on reporting guidelines for biomedical literature reviews maps type to guideline, and what PRISMA is and is not addresses the most common misuse of the main statement.
Paired do’s and don’ts across the life of a review
| Stage | Do | Don’t |
|---|---|---|
| Review type | Name the type, define it in the methods, and justify the choice | Treat “literature review” as a method, or claim a type the methods do not deliver |
| Reporting guideline | Report to the guideline that matches the type — PRISMA 2020 with PRISMA-S, or PRISMA-ScR for a scoping review | Report a scoping review against the main PRISMA checklist, which omits the items its readers require |
| Search | Specify sources with interfaces, coverage and run dates, and the full executed strategy | Call the search comprehensive, or list a non-reproducible source alongside bibliographic databases |
| Screening | Report screener numbers, independence and the disagreement procedure; record exclusion reasons at full text | Write “relevant studies were selected”, or leave screening by a single reviewer unreported |
| Counts | Reconcile the abstract, flow diagram, text and tables as a deliberate final step | Assume they still agree after a late addition or removal |
| Appraisal | Use an instrument matched to the included designs and report results study by study | Describe studies instead of judging them, or let volume stand in for evidence |
| Synthesis | Organise around claims about the body of work, and explain disagreement | Narrate study by study, or list conflicting findings without engaging them |
| Limitations | State the limitations arising from the search, screening, included literature and synthesis | Write a generic paragraph, or undermine the entire review |
Guideline requirements as published: PRISMA 2020 (Page and colleagues, BMJ), PRISMA-S (Rethlefsen and colleagues, Systematic Reviews), PRISMA-ScR (Tricco and colleagues, Annals of Internal Medicine); review-type requirements from Grant and Booth, Health Information and Libraries Journal.
Reproducible reporting of the search strategy
Do write the search section as a set of instructions. Don’t write it as a description. The difference can be tested: if a colleague in the same field, given the methods section, could not reproduce the record count, the section is a description.
PRISMA-S, published by Rethlefsen and colleagues in Systematic Reviews, specifies sixteen items that between them cover the databases, the dates, the full strategies and the supplementary methods used 31. The items most often omitted are those that matter most. Each source should be named with its interface, because the platform affects what a search returns 31,36. Both the coverage dates and the date on which the search was run should be given, together with the re-run date if applicable. The full line-by-line strategy for every database should be provided in an appendix, as executed rather than paraphrased. Every limit and filter should be listed with a justification, since each constitutes a systematic exclusion. The supplementary methods — backward and forward citation checking, hand-searching, trial registers, grey literature, author contact — should be enumerated separately rather than compressed into “additional articles were identified”.
Don’t include a source that cannot be searched reproducibly in a list of sources that can. Web search tools and general academic search engines have a role in scoping and supplementary searching, but listing one alongside MEDLINE and Embase implies a line-by-line strategy that does not exist 1. State where it was used and for what purpose. Search strategy peer review is the formal check, and literature search and citation support is where the strategy is developed.
Reporting of screening procedures and resolution of disagreement
Do report the number of screeners at each stage, whether they worked independently, and the procedure for resolving disagreement 15,32. Don’t write “relevant studies were selected”, which describes an outcome and conceals a method.
Screening is the stage at which the inclusion set is created, and it is the step a reader can least reconstruct from the output. Three sentences suffice: how many people screened titles and abstracts, and whether independently; the same for full texts; and how disagreements were resolved — discussion, a third reviewer, or a pre-specified rule. Reasons for exclusion should be recorded at the full-text stage, because that is where judgement was exercised and where a reader most needs to see it.
Don’t conceal single-handed screening, and don’t apologise for it either. Where one person screened, the appropriate approach is to double-screen a documented sample, report the agreement, have the exclusions re-checked, and state the limitation with that figure attached. A quantified limitation reads as method; an unmentioned one suggests that the author hoped the question would not be asked. Abstract screening from beginning to end covers the procedure and handling discrepancies in data collection covers the arbitration step.
Reconciliation of study counts before submission
Do check that the record counts agree across the abstract, the flow diagram, the results text and any table that reports them 32. Don’t assume that they agree because they did in an earlier draft; they diverge when a study is added or removed late and only one location is updated.
The risk is not hypothetical. Sabiri, Sousa and Rocha’s systematic review of privacy-preserving blockchain applications in healthcare, published in Multimedia Tools and Applications, reports 58 included studies in the abstract and 52 in the body 5. The review may be sound; the discrepancy nonetheless requires a reader to decide which number to believe before using anything else in it, and a methodological reviewer will raise it before engaging with the findings.
When counts are reported correctly, they convey information. Wang and colleagues, in the Journal of Medical Internet Research, retained 111 documents after full-text screening in their systematic literature review of blockchain for securing federated learning in the medical field — a figure indicating that the field is substantial 4. Schmeelk, Kanabar, Peterson and Pathak’s scoping review of electronic health records and blockchain interoperability requirements, in JAMIA Open, included 15 of 152 screened publications — a ratio indicating that the eligibility criteria were narrow relative to the search, which is itself a finding about how little of a large literature addresses interoperability requirements directly 23. Both numbers are informative because they reconcile; neither would be if the abstract reported a different figure. See extracting quantitative data for a review for maintaining consistent counts during extraction.
What the record counts tell a reader, using reviews of blockchain for health data
| Review | Counts as reported | What the reader learns |
|---|---|---|
| Systematic literature review of blockchain for securing federated learning in the medical field — Wang and colleagues, Journal of Medical Internet Research | 111 documents retained after full-text screening | The field is substantial enough to support a structured review |
| Scoping review of EHR and blockchain interoperability requirements — Schmeelk, Kanabar, Peterson and Pathak, JAMIA Open | 15 included of 152 screened | Eligibility was narrow relative to the search — little of a large literature addresses interoperability requirements directly |
| Systematic review of blockchain for health data sharing | 334 studies analysed; 1 retracted paper excluded | A large literature, with retraction checking shown to have been done |
| Systematic review of privacy-preserving blockchain applications in healthcare — Sabiri, Sousa and Rocha, Multimedia Tools and Applications | 58 included studies in the abstract; 52 in the body | A reader must choose which number to believe before using anything else |
Counts as reported in each publication. The last row is cited as an illustration of why reconciliation is a necessary final step, not as a judgement on that review’s conduct.
An unreconciled count in a published, peer-reviewed systematic review. Figures as reported in Sabiri K, Sousa F, Rocha T. A systematic review of privacy-preserving blockchain applications in healthcare. Multimedia Tools and Applications.
Critical appraisal of included studies in an emerging field
Do appraise the included studies and report the appraisal. Don’t substitute description for appraisal, which is the most common weakness in health care reviews that are otherwise well conducted.
Appraisal prevents volume from substituting for evidence. The blockchain health-data literature illustrates this gap clearly: a systematic review analysing 334 studies, with one retracted paper excluded, found that most proposals are at technology readiness level 3 — experimental proof of concept rather than technology deployed or evaluated in service 42. A review that counted those 334 papers and reported their growth would lead a reader to conclude the opposite of what the evidence supports. The appraisal step converts a large literature into an accurate statement: that much has been proposed and little tested 42.
Two specific practices should be incorporated. First, the appraisal instrument should be matched to the included study designs, applied by a stated number of assessors, and reported study by study rather than as a global adjective 14,28. Second, retractions and expressions of concern should be checked before any study is included; the single retracted paper excluded from that 334-study review demonstrates that a retracted study would otherwise remain in the synthesis unmarked. Don’t use the appraisal to disqualify everything either: in an emerging field the appropriate conclusion is usually that the proposals are plausible and the evaluations are lacking, which is a finding on which a reader can act. A worked treatment of this literature is available at blockchain for data sharing in biomedical research.
Synthesis in place of sequential narration
Do organise the results around claims about the body of work. Don’t organise them around individual studies in sequence, which produces a familiar and tedious paragraph structure: author, year, design, finding; next author, year, design, finding.
The test is the position of the study names in the sentence. In serial narration they are the subject — “Smith and colleagues found…”. In synthesis the subject is the pattern, and the studies are the evidence for it — “All four randomised studies reported a reduction, while the three cohort studies did not, a difference that tracks how exposure was measured rather than the population studied.” The second form is more difficult to write because it requires the author to have determined what the literature shows, which is the substance of the task.
In practice, this involves grouping by concept, outcome, population or methodological feature rather than by paper, and stating each group’s conclusion before the supporting detail 9,33. It also involves explaining disagreement rather than merely reporting it: where studies conflict, the candidate explanations — design, population, measurement, analysis, timing — should be presented, with a statement of which the evidence favours or that it cannot distinguish between them 9. A review that lists contradictory findings without addressing them leaves the reader with the problem the review was intended to solve.
A results paragraph in a health care literature review
Serial narration
Smith et al. (2021) conducted a randomised trial in 240 patients and found a significant reduction in the primary outcome. Jones et al. (2022) performed a retrospective cohort study in 1,800 patients and found no significant difference. Patel et al. (2023) carried out a before-and-after study in a single centre and reported an improvement. Lee et al. (2023) conducted a randomised trial and also found a reduction. Overall, the results of the studies were mixed, and further research is needed.
The studies are the subject of every sentence. The reader is presented with a reading list in prose and left to perform the synthesis.
“Mixed” summarises the author’s uncertainty rather than stating a finding. The disagreement is the most informative feature of this literature, yet the paragraph treats it as an obstacle.
Design and finding are reported side by side but never connected. The pattern — positive trials, null cohorts — is present in the text but not remarked upon.
Sample sizes are given without interpretive use. They are relevant because they bear on how the cohorts were assembled, which is not stated.
“Further research is needed” concludes without posing a question. It identifies no specific missing study and therefore provides no guidance, including to the author.
Synthesis
Across the seven included studies the direction of effect tracked the study design rather than the population. Both randomised trials reported a reduction in the primary outcome, as did the two before-and-after studies, while the three retrospective cohorts found no difference. The cohorts were substantially larger and drawn from routine records, in which exposure was ascertained from prescribing data rather than confirmed at the point of administration; non-differential misclassification of exposure would be expected to attenuate an effect towards the null, which is consistent with what they report. The alternative explanation — that the randomised results reflect selected populations with better adherence — cannot be excluded on the available data, because none of the trials reported adherence separately. What the body of evidence supports at present is a probable reduction under trial conditions, of uncertain size in routine care.
The first sentence states a claim about the whole body of work, which the rest of the paragraph supports; the studies are evidence rather than topics.
The disagreement is explained by a named mechanism — exposure ascertainment — with a stated direction of bias, so the reader can evaluate the explanation rather than accept it.
A competing explanation is given and the reason it cannot be ruled out is specified, which distinguishes balanced synthesis from advocacy.
The closing sentence states what the evidence currently supports and where the uncertainty lies, which is informative: it indicates to a clinician what to expect and to a researcher what to measure.
Nothing is overstated. “Probable” and “of uncertain size” are calibrated to a literature of seven studies with a design-aligned split.
The second paragraph could be quoted in a guideline discussion; the first could not. The difference lies not in writing skill but in the fact that the author of the second version determined what the literature shows and took responsibility for that determination.
Use of a verifiable academic register
Do prefer specific, attributable statements. Don’t use intensifiers and vague quantifiers, which read as padding and cannot be verified 20. “Numerous studies have shown” is weaker than “three cohort studies, all in secondary care, reported”, and it is weaker precisely because it cannot be checked.
Four practices are recommended. Authors should quantify where possible and state what is being counted: how many studies, in which populations, with which designs. Claims should be attributed to their sources rather than to the literature in general, since “it is widely accepted” is an appeal to a consensus that no one is required to document. Tense should be consistent: what a study did and found is reported in the past tense, and what the field currently holds in the present. Finally, what the evidence shows should be distinguished from what the author considers it implies, in separate sentences, so that a reader can disagree with the latter without rejecting the former 7.
Don’t cite secondhand. A reference identified in another paper’s reference list should be read in the original before use; otherwise any error introduced by the intermediate author is propagated 17. And don’t cite a guideline or tool without confirming that the intended version is cited, since both are revised while outdated citations continue to circulate. Reference validation is the systematic version of this check.
Statement of known limitations
Do name the limitations that follow from the review’s own method. Don’t write a generic limitations paragraph, which suggests that the specific limitations of the review have not been considered.
For a literature review, the substantive limitations almost always lie in four areas. The search: which sources were not used, which languages were excluded, whether grey literature and registers were covered, and when the search ended 31. Screening and extraction: how many people were involved, and whether they worked independently. The included literature: its size, its design mix and its maturity — the technology readiness level point applies to any review of an emerging intervention, not only to blockchain. The synthesis: whether the studies were sufficiently similar to be combined in the manner chosen 32.
Stating these limitations has a further benefit beyond transparency. A limitation stated by the authors is one that a reviewer does not need to discover, and the two situations are perceived very differently. Don’t use the limitations section to undermine the whole review either; the useful form names the constraint and states what it does and does not affect. Pubrica’s reporting checklist review and clinical literature review services are built around these four areas, and the five mistakes that weaken a review addresses which of them can still be corrected at a late stage.
Key points
Key points
The credibility of a health care literature review depends on its methodological reporting. Authors should declare the review type and report according to its guideline: PRISMA 2020 with the sixteen PRISMA-S search items for a systematic review, and the 20 essential and 2 optional PRISMA-ScR items for a scoping review. Sources should be specified with their interfaces, coverage and run dates, and the executed strategy provided in an appendix. The number of screeners, whether they worked independently, and the method of resolving disagreement should be stated. Every count should be reconciled as a deliberate final step; a published review reporting 58 included studies in its abstract and 52 in its body illustrates how readily such errors occur. Studies should be appraised rather than described, because volume does not indicate maturity: a review of 334 blockchain health-data studies found most proposals at technology readiness level 3. Results should be organised around claims about the body of evidence, disagreement should be explained rather than merely reported, and the limitations arising from the review method should be stated explicitly.
Application to your study
Application to your study
- Write the sentence declaring the review type first. The sentence should name, define and justify the review type and identify the reporting guideline to be used. Every conclusion in the draft should then be checked to confirm that the review type can support it.
- Restructure the search section as a set of reproducible instructions. The section should specify sources with interfaces, coverage dates, run and re-run dates, full executed strategies in an appendix, a justification for every limit, and each supplementary method listed separately.
- Include the three sentences describing screening. These should state the screeners and their independence at the title and abstract stage, the same at the full-text stage, and the procedure for resolving disagreement. If screening was conducted by a single reviewer, a sample should be double-screened, the agreement reported and the limitation stated.
- Reconcile the numbers in a separate review. The abstract, flow diagram, results text and tables should be compared, with reasons recorded for every full-text exclusion. This step should be completed after the final study has been added.
- Appraise studies with an instrument appropriate to their designs, and check for retractions. The appraisal should be reported for each study, with an explicit statement where the literature consists of proposals rather than evaluations.
- Rewrite one results paragraph as synthesis and compare the two versions. The pattern across studies should be the subject of each sentence, candidate explanations for any disagreement should be given, and the current conclusions supported by the body of evidence should be stated.
Frequently asked questions
Sufficient detail for an independent reader to repeat it. Specifically: the review type and its definition; the reporting guideline followed; every information source named with its interface; coverage dates and the date the search was run; the full line-by-line strategy as executed, usually in an appendix; every limit and filter with a justification; each supplementary search method listed separately; the number of screeners at title, abstract and full-text stages and whether they worked independently; the disagreement procedure; the appraisal instrument and number of assessors; and the synthesis approach. PRISMA-S covers the search component in sixteen items. The test of completeness is whether a colleague in the same field could reproduce the record count from the section.
Not the main PRISMA checklist, which is designed for systematic reviews; the search should nonetheless be reported transparently and the review type stated. The practical approach is to use PRISMA-S for the search section regardless of review type, since reproducible search reporting is also useful in a narrative review, and to state clearly in the methods that the review is narrative and why. It is not acceptable to borrow the credibility of the guideline without its apparatus: stating that a narrative review was “conducted according to PRISMA” claims both a method PRISMA does not describe and a review type that was not conducted.
By changing the subject of the sentences. In serial narration the study is the grammatical subject — “Smith and colleagues found…”. In synthesis the pattern is the subject and the studies are the evidence — “Both randomised trials reported a reduction while the three cohorts did not, a split that tracks how exposure was ascertained.” In practice, results should be grouped by concept, outcome, population or design feature rather than by paper; each group’s conclusion should be stated before the supporting detail; and where studies disagree, the candidate explanations should be given with a statement of which the evidence favours. Inability to write the grouping sentence indicates that the analysis has not yet been done, which is an analytical rather than a writing problem.
Almost always because a study was added or removed late and only one location was updated. Reconciliation should be treated as a distinct final step rather than assumed, because the inconsistency is both common and highly visible: Sabiri, Sousa and Rocha’s review of privacy-preserving blockchain applications in healthcare reports 58 included studies in its abstract and 52 in its body, in a peer-reviewed journal. The abstract, the flow diagram, the results text and every table should be checked against one another after the inclusion set is finalised, and the diagram arithmetic should be confirmed to run from records identified through duplicates removed, records screened, and full texts assessed and excluded with reasons, to studies included.
They should be appraised on what they claim to show, and the maturity of the evidence should be reported as a finding rather than a caveat. In an emerging area most publications are proposals, prototypes or proofs of concept, and treating them as evaluations misrepresents the field. A systematic review of blockchain for health data sharing analysed 334 studies and found most proposals at technology readiness level 3 — experimental proof of concept. This is a usable conclusion: proposals are numerous, whereas clinical evaluations are not. An appraisal instrument matched to the included designs should be used and reported study by study, retractions and expressions of concern should be checked, and both dismissal and overstatement should be avoided.
PRISMA-ScR, published by Tricco and colleagues in the Annals of Internal Medicine. It comprises 20 essential reporting items plus 2 optional items, and was developed by a 24-member expert panel working with 2 research leads. It exists because a scoping review answers a different question from a systematic review — mapping the extent, range and nature of a literature rather than estimating an effect — and therefore requires different reporting: how the mapping was structured, how charting was done, and what the map shows about gaps. Reporting a scoping review against the main PRISMA 2020 checklist produces a document that omits the items its readers require and implies a synthesis that was never attempted.
Those that follow from the review’s own method, in four areas. The search: sources not used, languages excluded, whether grey literature and trial registers were covered, and the date on which it ended. Screening and extraction: how many people were involved and whether they worked independently. The included literature: how many studies, what mix of designs, and how mature the work is — proposals versus evaluations. The synthesis: whether the included studies were sufficiently similar to be combined in the manner chosen. Each limitation should be written as a specific sentence that states what it does and does not affect. Generic limitations paragraphs are worse than none, because they indicate that the specific limitations were not considered.
Only after the original has been read. Taking a citation from another paper’s reference list means inheriting any error that author made, and reviews are where such errors propagate fastest because secondhand citation is easiest there. The practical rule is that any reference cited substantively — for a finding, a number or a method — should be read. For guidelines, checklists and tools, authors should confirm that they are citing the intended version, since these are revised while old citations continue to circulate; PRISMA, for instance, has a 2020 statement and several extensions, and citing the wrong one in a methods section suggests to a reviewer a lack of care in the rest of the work.
References
- Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Metzendorf M-I, Noel-Storr A, Paynter R, Rader T, Thomas J, Wieland LS. Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5.1. Cochrane. 2025;6.5.1(Chapter 4). read 9 October 2026. cochrane.org
- Soohoo SL, Keller MS, Chen Y, Hu D, Huang S-C, Kuo T-T, Leder C, Lu X, Meeker D, Morse B, Moyse H, Nagaraj G, Nguyen AT, Schilling LM, Soares A, Whooley MA, Zheng K, Ohno-Machado L. Development of the authentication and authorization processes for the iAgree portal, a platform for patient-controlled data sharing across health systems. JAMIA Open. 2026;9(3):ooag111. doi:10.1093/jamiaopen/ooag111 read 9 October 2026. doi.org/10.1093/jamiaopen/ooag111
- Drew S, Tang G, Saad Z, Zhou J, Chen Y, Wang F. Patient-governed agentic health data exchange. npj Health Systems. 2026;3(1):94. doi:10.1038/s44401-026-00155-3 read 9 October 2026. doi.org/10.1038/s44401-026-00155-3
- Wang X, Xie Y, Chen X, Yang J, Li R, Gao W, Yan Z, Zhou H, Ye Z. Securing Federated Learning With Blockchain in the Medical Field: Systematic Literature Review. Journal of Medical Internet Research. 2026;28(1):e79052. doi:10.2196/79052 read 9 October 2026. doi.org/10.2196/79052
- Sabiri K, Sousa F, Rocha T. A systematic review of privacy-preserving blockchain applications in healthcare. Multimedia Tools and Applications. 2025;84(32):39925-39980. doi:10.1007/s11042-024-20541-z read 9 October 2026. doi.org/10.1007/s11042-024-20541-z
- Welzel C, Ostermann M, Smith HL, Minssen T, Kirsten T, et al., Gilbert S. Enabling secure and self determined health data sharing and consent management. npj Digital Medicine. 2025;8(1):560. doi:10.1038/s41746-025-01945-z read 9 October 2026. doi.org/10.1038/s41746-025-01945-z
- Houser J, Oja K. Nursing Research: Reading, Using, and Creating Evidence (6th edition). 2025;6th edition. read 9 October 2026. swslhd.libguides.com
- Pan ML. Preparing Literature Reviews: Qualitative and Quantitative Approaches (6th edition). 2025;6th edition. read 9 October 2026. swslhd.libguides.com
- Booth A, Sutton A, Clowes M, Martyn-St James M. Systematic Approaches to a Successful Literature Review (4th edition). 2025;4th edition. read 9 October 2026. collegepublishing.sagepub.com
- Kim K, Kim S-M, Park Y, Lee E, Jung S, Kang J, An D, Min K, Shim SR, Yu HW, Han HW. A blockchain-based healthcare data marketplace: prototype and demonstration. JAMIA Open. 2024;7(2):ooae029. doi:10.1093/jamiaopen/ooae029 read 9 October 2026. doi.org/10.1093/jamiaopen/ooae029
- Khurshid A, Harrell DT, Li D, Hallmark C, Hanson L, Viswanathan N, Carr M, Brown A, McNeese M, Fujimoto K. Designing a blockchain technology platform for enhancing the pre-exposure prophylaxis care continuum. JAMIA Open. 2024;7(4):ooae140. doi:10.1093/jamiaopen/ooae140 read 9 October 2026. doi.org/10.1093/jamiaopen/ooae140
- Webb P, Bain C, Page A. Essential Epidemiology (5th edition). 2024;5th edition. read 9 October 2026. swslhd.libguides.com
- Bettany-Saltikov J, McSherry R. How To Do a Systematic Literature Review in Nursing: A Step by Step Guide (3rd edition). 2024;3rd edition. read 9 October 2026. swslhd.libguides.com
- Greenhalgh T, Dijkstra P. How to Read a Paper: The Basics of Evidence-Based Healthcare (7th edition). 2024;7th edition. read 9 October 2026. swslhd.libguides.com
- Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z (editors). JBI Manual for Evidence Synthesis. JBI. 2024;2024 edition. read 9 October 2026. jbi-global-wiki.refined.site
- Ballhausen H, Corradini S, Belka C, Bogdanov D, Boldrini L, Bono F, Goelz C, Landry G, Panza G, Parodi K, Talviste R, Tran HE, Gambacorta MA, Marschner S. Privacy-friendly evaluation of patient data with secure multiparty computation in a European pilot study. npj Digital Medicine. 2024;7(1):280. doi:10.1038/s41746-024-01293-4 read 9 October 2026. doi.org/10.1038/s41746-024-01293-4
- Marusic A (editor). A Guide to Responsible Research. 2023. read 9 October 2026. swslhd.libguides.com
- Aveyard H. Doing a Literature Review in Health and Social Care: A Practical Guide (5th edition). 2023;5th edition. read 9 October 2026. swslhd.libguides.com
- Miller DV, Revelo MP (editors). Doing a Systematic Review. 2023. read 9 October 2026. swslhd.libguides.com
- Johnstone MJ. Effective Writing for Healthcare Professionals (2nd edition). 2023;2nd edition. read 9 October 2026. swslhd.libguides.com
- Oermann MH. Writing for Publication in Nursing (5th edition). 2023;5th edition. read 9 October 2026. swslhd.libguides.com
- Holly C, Salmond S, Saimbert M. Comprehensive Systematic Review for Advanced Practice Nursing (3rd edition). 2022;3rd edition. read 9 October 2026. swslhd.libguides.com
- Schmeelk S, Kanabar M, Peterson K, Pathak J. Electronic health records and blockchain interoperability requirements: a scoping review. JAMIA Open. 2022;5(3):ooac068. doi:10.1093/jamiaopen/ooac068 read 9 October 2026. doi.org/10.1093/jamiaopen/ooac068
- Dekkers R, Carey L, Langhorne P. Making Literature Reviews Work: A Multidisciplinary Guide to Systematic Approaches. 2022. read 9 October 2026. swslhd.libguides.com
- Price C. Syntheses Synthesized: A Look Back at Grant and Booth's Review Typology. Evidence Based Library and Information Practice. 2022;17(2). doi:10.18438/eblip30093 read 9 October 2026. doi.org/10.18438/eblip30093
- Khan KS, Zamora J. Systematic Reviews to Support Evidence-Based Medicine (3rd edition). 2022;3rd edition. read 9 October 2026. swslhd.libguides.com
- Machi LA, McEvoy BT. The Literature Review: Six Steps to Success (4th edition). 2022;4th edition. read 9 October 2026. swslhd.libguides.com
- Perry R, Whitmarsh A, Leach V, et al. A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2. Systematic Reviews. 2021;10:273. doi:10.1186/s13643-021-01819-x read 9 October 2026. doi.org/10.1186/s13643-021-01819-x
- Khurshid A, Holan C, Cowley C, Alexander J, Harrell DT, Usman M, Desai I, Bautista JR, Meyer E. Designing and testing a blockchain application for patient identity management in healthcare. JAMIA Open. 2021;4(3):ooaa073. doi:10.1093/jamiaopen/ooaa073 read 9 October 2026. doi.org/10.1093/jamiaopen/ooaa073
- Coughlan M, Cronin P. Doing a Literature Review in Nursing, Health and Social Care (3rd edition). 2021;3rd edition. read 9 October 2026. swslhd.libguides.com
- Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB; PRISMA-S Group. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Systematic Reviews. 2021;10(1):39. doi:10.1186/s13643-020-01542-z read 9 October 2026. doi.org/10.1186/s13643-020-01542-z
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71 read 9 October 2026. doi.org/10.1136/bmj.n71
- Braun V, Clarke V. Thematic Analysis: a practical guide to understanding and doing. 2021. read 9 October 2026. swslhd.libguides.com
- Inan OT, Tenaerts P, Prindiville SA, Reynolds HR, Dizon DS, Cooper-Arnold K, Turakhia M, Pletcher MJ, Preston KL, Krumholz HM, Marlin BM, Mandl KD, Klasnja P, Spring B, Iturriaga E, Campo R, Desvigne-Nickens P, Rosenberg Y, Steinhubl SR, Califf RM. Digitizing clinical trials. npj Digital Medicine. 2020;3(1):101. doi:10.1038/s41746-020-0302-y read 9 October 2026. doi.org/10.1038/s41746-020-0302-y
- Sutton A, Clowes M, Preston L, Booth A. Meeting the review family: exploring review types and associated information retrieval requirements. Health Information and Libraries Journal. 2019;36(3):202-222. doi:10.1111/hir.12276 read 9 October 2026. doi.org/10.1111/hir.12276
- Burns CS, Shapiro RM II, Nix T, Huber JT. Search results outliers among MEDLINE platforms. Journal of the Medical Library Association. 2019;107(3):364-373. doi:10.5195/jmla.2019.622 read 9 October 2026. doi.org/10.5195/jmla.2019.622
- Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tuncalp O, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine. 2018;169(7):467-473. doi:10.7326/M18-0850 read 9 October 2026. doi.org/10.7326/M18-0850
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4:1. doi:10.1186/2046-4053-4-1 read 9 October 2026. doi.org/10.1186/2046-4053-4-1
- Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Information and Libraries Journal. 2009;26(2):91-108. doi:10.1111/j.1471-1842.2009.00848.x read 9 October 2026. doi.org/10.1111/j.1471-1842.2009.00848.x
- GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology. read 9 October 2026. jclinepi.com
- Roga E, Pruis K. Introducing Scoping and Systematic Reviews. read 9 October 2026. swslhd.libguides.com
- Privacy preservation in blockchain-based healthcare data sharing: A systematic review. doi:10.1007/s12083-025-02148-9 read 9 October 2026. doi.org/10.1007/s12083-025-02148-9
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis. Pubrica. https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/
Pubrica Academy. “Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis.” Pubrica, 9 Oct. 2026, pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/.
Pubrica Academy (2026) Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis. Pubrica. Available at: https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/ (Accessed: 15 October 2026).
Pubrica Academy. “Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis.” Pubrica. October 9, 2026. https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/
Pubrica Academy, ‘Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/> accessed 15 October 2026.
Pubrica Academy. Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/
Pubrica Academy, “Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/
@misc{dos_and_donts_in_writing_a_scientific__2026,
author = {{Pubrica Academy}},
title = {Do’s and Don’ts in Writing a Scientific Literature Review for Health Care Research: Methodological Reporting and Synthesis},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/medical-writing/dos-and-donts-in-writing-a-scientific-literature-review-for-health-care-research/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Pre-submission do’s and don’ts checklist
This list should be worked through with the draft open. Each line requires either a tick or a sentence to be written. The DON’T lines are phrases to search for in the manuscript and remove.
HEALTH CARE LITERATURE REVIEW: PRE-SUBMISSION CHECK
A. TYPE AND GUIDELINE
Review type: ______________________
Defined in the methods? [ ]
Justification given? [ ]
Reporting guideline used: ______________________
[ ] Title claims only what the methods deliver
[ ] Every conclusion is one this review type supports
B. SEARCH (a stranger must be able to re-run it)
[ ] Each source named WITH interface/platform
[ ] Coverage dates for each source
[ ] Date search run: ______ Re-run date: ______
[ ] Full line-by-line strategy, as executed, in Appendix ____
[ ] Records retrieved per source reported
[ ] Every limit/filter listed with a justification
[ ] Supplementary methods listed separately:
[ ] backward citations [ ] forward citations
[ ] hand-searching [ ] trial registers
[ ] grey literature [ ] author contact
[ ] Non-reproducible sources described separately, not listed as databases
[ ] Sources NOT searched stated
C. SCREENING
Title/abstract: ____ screeners independent? [ ]
Full text: ____ screeners independent? [ ]
Disagreement resolved by: ______________________
[ ] Reasons recorded for every full-text exclusion
If single-handed: sample double-screened ____ records,
agreement ______, limitation stated [ ]
D. COUNT RECONCILIATION (do this LAST)
Included studies stated in: abstract ____ flow diagram ____
results text ____ tables ____
[ ] All four agree
[ ] Flow diagram arithmetic runs at every stage
[ ] Studies included vs studies in synthesis difference explained
E. APPRAISAL
Instrument: ______________ Assessors: ____
[ ] Instrument matches the included study designs
[ ] Result reported study by study, not as one adjective
[ ] Retractions and expressions of concern checked
[ ] Maturity of the evidence stated (proposals vs evaluations)
F. SYNTHESIS
[ ] Results grouped by concept/outcome/design, not by paper
[ ] Each group opens with its conclusion
[ ] Disagreements given candidate explanations
[ ] Statement of what the body of evidence currently supports
G. PHRASES TO FIND AND REMOVE
[ ] "a comprehensive search was performed"
[ ] "relevant studies were selected"
[ ] "numerous studies have shown" / "it is widely accepted"
[ ] "the results were mixed"
[ ] "further research is needed" with no specific missing study
[ ] "conducted according to PRISMA"
H. LIMITATIONS (write one specific sentence for each)
Search: ______________________________________
Screening/extraction: ________________________
Included literature: _________________________
Synthesis: ___________________________________ Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s review teams assess health care literature reviews against the checks applied by a methodological reviewer: whether the declared review type corresponds to the methods, whether the search as reported could be repeated, whether the counts reconcile across the abstract, flow diagram and text, and whether critical appraisal has been conducted. Pubrica restructures search sections according to the PRISMA-S items, maps the draft against PRISMA 2020 or PRISMA-ScR as the review type requires, and rewrites sequentially narrated results as synthesis where the analysis supports it. Where the analysis does not support synthesis, Pubrica states this, because it is a finding rather than an editorial problem.